Javid J Moslehi MD

Summary

• I am a cardiologist and myocyte biologist. My clinical focus is cardio-oncology (the cardiovascular care of cancer patients and cancer survivors). My basic and translational NIH-funded laboratory addresses myocardial responses to various stresses including hypoxia, aging and toxins. Over the last several years, given my clinical interest in cardio-oncology, my laboratory focus has been in delineating the mechanistic underpinnings of cardiovascular toxicities from novel targeted cancer therapies. I believe because of the targeted nature of the toxicities, cardio-oncology can provide insights into novel signaling pathways that are relevant in human cardiovascular biology and pathology.
  
  At University of California, San Francisco (UCSF), I am the William Grossman Distinguished Professor of Cardiology and Associate Professor in Residence and Founding Chief of a new section focused on Cardio-Oncology and Immunology. I work closely with cardiologists and oncologists, basic and translational researchers and clinicians locally, nationally and internationally. I have multiple collaborations with industry and regulatory bodies (including the US FDA). In 2019, I was named the first chair of the American Heart Association (AHA) cardio-oncology subcommittee. At Vanderbilt and UCSF, I established a Graduate Medical Education (GME) approved fellowship training the next generation of physician-scientists in the field of cardio-oncology. I am an elected member of American Society of Clinical Investigation (ASCI).